East Bay biotech pivoted to cancer, found new space — now CEO is leaving, 82 jobs are cut
May 24, 2019 at 17:41 PM EDT
The company is returning its focus to its easier-to-take hepatitis B vaccine and other vaccine work.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.